E Rossi

Summary

Affiliation: Western Australia
Country: Australia

Publications

  1. ncbi request reprint Variegate porphyria in Western Australian Aboriginal patients
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia, Australia
    Intern Med J 32:445-50. 2002
  2. doi request reprint High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis
    Enrico Rossi
    Biochemistry, PathWest, QE II Medical Centre, Nedlands, Western Australia, Australia
    Clin Chem Lab Med 51:1107-14. 2013
  3. doi request reprint Community blood lead survey with emphasis on preschool children following lead dust pollution in Esperance, Western Australia
    Enrico Rossi
    PathWest Laboratory Medicine, QE II Medical Centre, Nedlands, Western Australia 6009
    Aust N Z J Public Health 36:171-5. 2012
  4. doi request reprint Clinical penetrance of C282Y homozygous HFE hemochromatosis
    Enrico Rossi
    Biochemistry Section, PathWest, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia
    Expert Rev Hematol 1:205-16. 2008
  5. ncbi request reprint Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age
    Enrico Rossi
    Department of Clinical Biochemistry, PathWest Nedlands, Western Australia, Australia
    Ann Clin Biochem 43:233-6. 2006
  6. ncbi request reprint Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia
    Enrico Rossi
    PathCentre, QEII Medical Centre, Nedlands, WA, Australia
    Ann Epidemiol 16:206-12. 2006
  7. ncbi request reprint Expression of the HFE hemochromatosis gene in a community-based population of elderly women
    Enrico Rossi
    Department of Clinical Biochemistry, PathCentre Western Australian Centre for Pathology and Medical Research, Nedlands, Western Australia, Australia
    J Gastroenterol Hepatol 19:1150-4. 2004
  8. ncbi request reprint Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients
    Enrico Rossi
    Clinical Biochemistry, PathCentre, Nedlands, Western Australia, Australia
    Clin Chem 49:450-4. 2003
  9. ncbi request reprint Genotyping as a diagnostic aid in genetic haemochromatosis
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia, Australia
    J Gastroenterol Hepatol 14:427-30. 1999
  10. ncbi request reprint Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia 6009, Australia
    Clin Chem 46:162-6. 2000

Collaborators

Detail Information

Publications25

  1. ncbi request reprint Variegate porphyria in Western Australian Aboriginal patients
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia, Australia
    Intern Med J 32:445-50. 2002
    ..Survivors of shipwrecks along the Western Australian coast may have introduced a mutation for variegate porphyria into the Aboriginal population prior to first settlement...
  2. doi request reprint High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis
    Enrico Rossi
    Biochemistry, PathWest, QE II Medical Centre, Nedlands, Western Australia, Australia
    Clin Chem Lab Med 51:1107-14. 2013
    ....
  3. doi request reprint Community blood lead survey with emphasis on preschool children following lead dust pollution in Esperance, Western Australia
    Enrico Rossi
    PathWest Laboratory Medicine, QE II Medical Centre, Nedlands, Western Australia 6009
    Aust N Z J Public Health 36:171-5. 2012
    ..To assess the impact of airborne lead dust on blood lead levels in residents of Esperance, a regional Western Australian town, with particular reference to preschool children...
  4. doi request reprint Clinical penetrance of C282Y homozygous HFE hemochromatosis
    Enrico Rossi
    Biochemistry Section, PathWest, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia
    Expert Rev Hematol 1:205-16. 2008
    ..With genetic analyses becoming simpler to perform, new genetic modifiers of hepatic iron loading and liver fibrogenesis await identification...
  5. ncbi request reprint Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age
    Enrico Rossi
    Department of Clinical Biochemistry, PathWest Nedlands, Western Australia, Australia
    Ann Clin Biochem 43:233-6. 2006
    ..Although no mutations were found, the most likely cause for the early expression is the presence of novel mutations or gene(s)...
  6. ncbi request reprint Folate levels and cancer morbidity and mortality: prospective cohort study from Busselton, Western Australia
    Enrico Rossi
    PathCentre, QEII Medical Centre, Nedlands, WA, Australia
    Ann Epidemiol 16:206-12. 2006
    ..To test a community population for the hypothesis that carcinogenesis is related to blood folate levels...
  7. ncbi request reprint Expression of the HFE hemochromatosis gene in a community-based population of elderly women
    Enrico Rossi
    Department of Clinical Biochemistry, PathCentre Western Australian Centre for Pathology and Medical Research, Nedlands, Western Australia, Australia
    J Gastroenterol Hepatol 19:1150-4. 2004
    ..Recent studies suggest that the clinical penetrance of associated hereditary hemochromatosis, defined as either the C282Y homozygote or compound heterozygote HFE genotype status, is much lower than previously thought...
  8. ncbi request reprint Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients
    Enrico Rossi
    Clinical Biochemistry, PathCentre, Nedlands, Western Australia, Australia
    Clin Chem 49:450-4. 2003
    ..We investigated the predictive value of the proprietary FibroTest score to accurately identify significant fibrosis in Australian hepatitis C patients...
  9. ncbi request reprint Genotyping as a diagnostic aid in genetic haemochromatosis
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia, Australia
    J Gastroenterol Hepatol 14:427-30. 1999
    ..Two mutations in a newly described gene, HFE, have been proposed as genetic markers for the inherited iron overload disease, genetic haemochromatosis...
  10. ncbi request reprint Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia 6009, Australia
    Clin Chem 46:162-6. 2000
    ..Women who inherit heterozygosity for the C282Y mutation of the HFE gene may have increased serum iron indices and hemoglobin and are less likely to develop iron deficiency compared with women with the wild-type genotype...
  11. ncbi request reprint Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Western Australia 6009, Australia
    Clin Chem 47:202-8. 2001
    ..Heterozygotes for the C282Y mutation of the HFE gene may have altered hematology indices and higher iron stores than wild-type subjects...
  12. ncbi request reprint Biological variability and reference intervals for total plasma homocysteine
    E Rossi
    Biochemistry Section, PathCentre, QE II Medical Centre, Nedlands, Australia
    Ann Clin Biochem 36:56-61. 1999
    ..An 'ideal' homocysteine reference range, based on targeting those subjects who are likely to be folate replete, is preferable to the population-based range using the central 0.95 interval...
  13. ncbi request reprint Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population
    E Rossi
    Department of Clinical Biochemistry, PathCentre, Queen Elizabeth II Medical Centre, Nedlands, Western Australia
    Stroke 31:3015-20. 2000
    ..The purpose of the study was to test whether either is a risk predictor for asymptomatic carotid atherosclerosis...
  14. ncbi request reprint Effects of body iron stores and haemochromatosis genotypes on coronary heart disease outcomes in the Busselton health study
    Christopher J Fox
    Department of Gastroenterology, Fremantle Hospital, Fremantle, Western Australia, Australia
    J Cardiovasc Risk 9:287-93. 2002
    ..The aims of this study were to determine in a stable community population whether increased iron stores or haemochromatosis gene mutations were risk factors for coronary heart disease...
  15. ncbi request reprint Hepatic iron loading in patients with compound heterozygous HFE mutations
    Ee Mun Lim
    Department of Clinical Biochemistry, PathCentre Western Australian Centre for Pathology and Medical Research, Nedlands, WA, Australia
    Liver Int 24:631-6. 2004
    ..To assess the severity of hepatic iron loading in patients with a compound heterozygous C282Y/H63D HFE genotype...
  16. doi request reprint Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk
    J Beilby
    Biochemistry Section, PathWest, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia
    Eur J Clin Nutr 64:1235-8. 2010
    ....
  17. ncbi request reprint Antioxidant inhibition of oxygen radicals for measurement of total antioxidant capacity in biological samples
    Simon Y L Ching
    PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre, Nedlands, Western Australia 6009, Australia
    Anal Biochem 353:257-65. 2006
    ..0254. Applications to measure antioxidant capacity are demonstrated on individual chemicals and biological samples. The method has good linearity, within- and between-assay precision, and recovery...
  18. doi request reprint The Fremantle lead study part 2
    Robin Guttinger
    Princess Margaret Hospital for Children, Fremantle, Australia
    J Paediatr Child Health 44:722-6. 2008
    ..A 1993 study of blood lead levels (BLLs) in pre-schoolers living in Fremantle showed 25% had BLLs >or= 10 microg/dL. This study compares the 1993 BLLs with a sample of contemporary Fremantle pre-schoolers...
  19. ncbi request reprint Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene
    J Beilby
    Clinical Biochemistry, PathCentre Locked Bag 2009, Nedlands, Western Australia 6009, Australia
    Eur J Cancer 40:1250-4. 2004
    ..01, 0.52) for the heterozygous C677T genotype. We conclude that for the whole group, and the wild-type and heterozygous C677T genotypes, increased serum concentrations of folate were associated with reduced risks of breast cancer...
  20. ncbi request reprint Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study
    Simon Ching
    Department of Clinical Biochemistry, PathCentre, Nedlands, Western Australia, 6009
    J Nutr 132:303-6. 2002
    ..26, 0.97) for bilirubin and 0.47 (CI 0.24, 0.94) for total antioxidant status. We conclude that increased serum levels of beta-carotene, retinol, bilirubin and total antioxidant status are associated with reductions in breast cancer risk...
  21. ncbi request reprint Inhibition of human lymphocyte ferrochelatase activity by hemin
    E Rossi
    Clinical Biochemistry Department, Queen Elizabeth II Medical Centre, Nedlands, Australia
    Biochim Biophys Acta 1038:375-81. 1990
    ..We conclude that the product inhibition of ferrochelatase by hemin should be considered as a possible site of regulation of heme biosynthesis...
  22. doi request reprint Comparison of cystatin C and creatinine as predictors of cardiovascular events in a community-based elderly population
    John Beilby
    Biochemistry Section, PathWest, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, Australia
    Clin Chem 56:799-804. 2010
    ..We compared 3 measures of renal function--serum cystatin C, serum creatinine, and calculated creatinine clearance--as predictors of subsequent cardiovascular events in a community-based population of elderly individuals...
  23. pmc Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study
    Timothy M E Davis
    School of Medicine and Pharmacology, Fremantle Hospital, University of Western Australia, Fremantle, Australia
    Diabetes Care 31:1795-801. 2008
    ..To examine the relationship between iron status, hereditary hemochromatosis (HFE) gene mutations, and clinical features and outcomes of type 2 diabetes in a well-characterized representative sample of community-based patients...
  24. ncbi request reprint Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection
    Leon A Adams
    Department of Gastroenterology and Hepatology, Sir Charles Gairdner Hospital, Perth, Australia
    Clin Chem 51:1867-73. 2005
    ..We sought to create an algorithm of serum markers that accurately and reliably predict liver fibrosis stage among hepatitis C patients...
  25. ncbi request reprint A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation
    Peter A Gochee
    Queensland Institute of Medical Research and the University of Queensland, Brisbane, Western Australia
    Gastroenterology 122:646-51. 2002
    ..We accessed a well-defined population in Busselton, Australia, and determined the frequency of the H63D mutation and its influence on total body iron stores...